Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt.

Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF, Pasare C.

Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):273-8. doi: 10.1073/pnas.1118579109. Epub 2011 Dec 20.

2.

Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Troutman TD, Bazan JF, Pasare C.

Cell Cycle. 2012 Oct 1;11(19):3559-67. doi: 10.4161/cc.21572. Epub 2012 Aug 16. Review.

3.

The role of MyD88-like adapters in Toll-like receptor signal transduction.

O'Neill LA.

Biochem Soc Trans. 2003 Jun;31(Pt 3):643-7. Review.

PMID:
12773173
4.

TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.

Brown J, Wang H, Hajishengallis GN, Martin M.

J Dent Res. 2011 Apr;90(4):417-27. doi: 10.1177/0022034510381264. Epub 2010 Oct 12. Review.

5.

Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.

Watters TM, Kenny EF, O'Neill LA.

Immunol Cell Biol. 2007 Aug-Sep;85(6):411-9. Epub 2007 Jul 31. Review.

PMID:
17667936
6.

Signalling of toll-like receptors.

Brikos C, O'Neill LA.

Handb Exp Pharmacol. 2008;(183):21-50. Review.

PMID:
18071653
7.

Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Futosi K, Fodor S, M├│csai A.

Int Immunopharmacol. 2013 Dec;17(4):1185-97. doi: 10.1016/j.intimp.2013.11.010. Epub 2013 Nov 18. Review.

PMID:
24263067
8.

TIR domain-containing adaptors define the specificity of TLR signaling.

Yamamoto M, Takeda K, Akira S.

Mol Immunol. 2004 Feb;40(12):861-8. Review.

PMID:
14698224
9.

Toll-like receptor downstream signaling.

Kawai T, Akira S.

Arthritis Res Ther. 2005;7(1):12-9. Epub 2004 Nov 30. Review.

10.

TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.

Seya T, Oshiumi H, Sasai M, Akazawa T, Matsumoto M.

Int J Biochem Cell Biol. 2005 Mar;37(3):524-9. Review.

PMID:
15618008
11.

TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.

Vogel SN, Fitzgerald KA, Fenton MJ.

Mol Interv. 2003 Dec;3(8):466-77. Review.

PMID:
14993454
12.

Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.

O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C.

J Endotoxin Res. 2003;9(1):55-9. Review.

PMID:
12691620
13.

Suppression of TLR signaling by targeting TIR domain-containing proteins.

Fekonja O, Avbelj M, Jerala R.

Curr Protein Pept Sci. 2012 Dec;13(8):776-88. Review.

14.

The structural network of inflammation and cancer: merits and challenges.

Guven Maiorov E, Keskin O, Gursoy A, Nussinov R.

Semin Cancer Biol. 2013 Aug;23(4):243-51. doi: 10.1016/j.semcancer.2013.05.003. Epub 2013 May 24. Review.

PMID:
23712403
15.

Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Ha T, Liu L, Kelley J, Kao R, Williams D, Li C.

Antioxid Redox Signal. 2011 Oct 1;15(7):1875-93. doi: 10.1089/ars.2010.3723. Epub 2011 Apr 8. Review.

16.

Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.

O'Neill LA.

Curr Top Microbiol Immunol. 2002;270:47-61. Review.

PMID:
12467243
17.

Toll-like receptor signaling in cell proliferation and survival.

Li X, Jiang S, Tapping RI.

Cytokine. 2010 Jan;49(1):1-9. doi: 10.1016/j.cyto.2009.08.010. Epub 2009 Sep 22. Review.

18.

What the Myddosome structure tells us about the initiation of innate immunity.

Gay NJ, Gangloff M, O'Neill LA.

Trends Immunol. 2011 Mar;32(3):104-9. doi: 10.1016/j.it.2010.12.005. Epub 2011 Jan 25. Review.

PMID:
21269878
19.

TLR signaling.

Kawai T, Akira S.

Cell Death Differ. 2006 May;13(5):816-25. Review.

20.

Adaptors in toll-like receptor signaling and their potential as therapeutic targets.

Ve T, Gay NJ, Mansell A, Kobe B, Kellie S.

Curr Drug Targets. 2012 Oct;13(11):1360-74. Review.

PMID:
22664090

Supplemental Content

Support Center